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A B S T R A C T
Surface display couples genotype with a surface exposed phenotype and thereby allows screening of
gene-encoded protein libraries for desired characteristics. Of the various display systems available, phage
display is by far the most popular, mainly thanks to its ability to harbour large size libraries. Here, we
describe the ﬁrst use of a Gram-positive bacterial host for display of a library of human antibody genes
which, when combined with phage display, provides ease of use for screening, sorting and ranking by
ﬂow cytometry. We demonstrate the utility of this method by identifying low nanomolar afﬁnity scFv
fragments towards human epidermal growth factor receptor 2 (HER2). The ranking and performance of
the scFv isolated by ﬂow sorting in surface-immobilised form was retained when expressed as soluble
scFv and analysed by biolayer interferometry, as well as after expression as full-length antibodies in
mammalian cells. We also demonstrate the possibility of using Gram-positive bacterial display to directly
improve the afﬁnity of the identiﬁed binders via an afﬁnity maturation step using random mutagenesis
and ﬂow sorting. This combined approach has the potential for a more complete scan of the antibody
repertoire and for afﬁnity maturation of human antibody formats.
© 2017 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Antibodies have become indispensable tools as research
reagents [1], in diagnostics [2] and as therapeutics [3–5]. To avoid
immunisation of animals and to better tune the molecular
characteristics of antibody reagents in vitro, several library-based
methods mimicking natural evolution for screening and identiﬁ-
cation of antibody-antigen interactions have been developed [6].
Phage display [7,8] is currently the most widely used selection
platform, its success mainly owing to its ability to conveniently
harbour large libraries together with ease of handling. Other
display formats include ribosome display [9,10] and cell based
display platforms such as E. coli [11], yeast [12] and mammalian
display [13]. The use of cell-based platforms offers several
advantages compared to the capture and elution procedure of
phage and ribosome display. Since cells, as opposed to phage, are
large enough to be detected by light scatter in a ﬂow cytometer,* Corresponding author.
E-mail address: johanr@biotech.kth.se (J. Rockberg).
http://dx.doi.org/10.1016/j.nbt.2017.07.011
1871-6784/© 2017 The Authors. Published by Elsevier B.V. This is an open access article uncells displaying a library of antibodies can be incubated with a
ﬂuorescently labeled antigen, allowing simultaneous real-time
screening and selection. As the stringency of the sorting can easily
be manipulated by changing the ﬂuorescence gate, the discrimi-
natory capacity and control of the system is superior [14]. In
addition, the multivalent copies of afﬁnity proteins displayed on
the cells enable quantitative screening of relative afﬁnities and
selected clones can subsequently be characterised individually by
ﬂow cytometry without the need for sub-cloning.
Currently, several cell-based display systems are available.
Yeast cells, being eukaryotic, possess glycosylation, disulphide-
bridge forming and protein folding machineries similar to those of
human cells. Differences, however, do exist between yeast and
human processing [15] and glycosylation is typically not desirable
during selection of scFv clones, as they will ultimately be
reformatted and expressed as full-length antibodies in mammalian
cell lines. Several display scaffolds derived from Gram-negative
bacteria have also been employed in surface display [16,17], where
E. coli is often the most commonly used host and its application in
isolation of antibodies from libraries has been reported [18].
Recognising the capabilities of yeast and E. coli as displayder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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positive bacteria in the selection of antibody fragments from
recombinant libraries. In contrast with Gram-negatives, the outer
layer of Gram-positive bacteria comprises only a single (plasma)
membrane and one layer of peptidoglycan, making the transloca-
tion of anchored fusion proteins straightforward. The thicker
peptidoglycan layer also acts as a physical barrier, protecting the
cells from the harsh environment in the ﬂow cytometer, leading to
increased cell viability after sorting, a key requirement of cell
surface display. Another key difference between Gram-negative
and Gram-positive bacteria is the difﬁculty of transformation of
the latter, which until lately [19] has made work in Gram-positive
hosts difﬁcult. Previous work has shown the potential of the Gram-
positive Staphylococcus carnosus to be used in the selection of
afﬁnity proteins and enzymes of bacterial origin [20,21], cysteine-
free camelid single domain antibodies [22], and for epitope
mapping of linear [23] and structural epitopes [24]. S. carnosus
surface display of a single murine scFv [25], as well as an attempt to
express a library of several human multi-domain proteins and
fragments [26], has further demonstrated the potential for this
platform to display folded, functional, complex human proteins.
Building on previous experience of S. carnosus as a robust host
for surface display and ﬂow sorting, here we have further
challenged it by using it as a platform for selection of human
antibody fragments. The aim of this proof-of-principle study was
to show the viability of this platform for selection and isolation of
high afﬁnity binders from antibody libraries. We demonstrate the
ﬁrst Gram-positive surface display of a human antibody library, by
subcloning into S. carnosus a synthetic human scFv library pre-
selected by phage display. We further show the combination of the
two display methods by isolation of scFv with low nanomolar
afﬁnity against human epidermal growth factor receptor 2 (HER2)
and demonstrate the usefulness of the Gram-positive platform as
an efﬁcient method for afﬁnity maturation. We propose Gram-
positive display as a convenient alternative for screening of
moderately sized antibody libraries, such as those pre-enriched by
phage display or afﬁnity maturation libraries. We suggest that the
combination of phage and Gram-positive bacterial display has the
potential for a more complete scanning of the antibody repertoire
than numerous individual ELISA screenings.
Materials and methods
Phage display selections and characterisation of anti-HER2 scFv
Phage from HelL-11, a human synthetic scFv library [27], were
cycled through rounds of selections with the extracellular domain
of HER2 (Sino Biological, Beijing, PR China) as capture target. The
antigen was covalently linked to magnetic beads with carboxylic
acids using amine coupling according to the manufacturer’s
instructions (Dynabeads; Life Technologies, Carlsbad, CA, USA).
Phage displaying nonspeciﬁc scFv were removed in a pre-selection
step by incubating the library diluted in TPBSB (0.05% Tween 20
and 1% BSA in PBS) with the same type of bead but containing no
antigen for 1 h at room temperature (RT) and slow rotation.
Subsequently the supernatant was transferred to the HER2-coated
beads and similarly incubated for 1.5 h. Following 4–7 rounds of
washing in TPBS (0.05% Tween 20 in PBS) using a KingFisher Flex
instrument (Thermo Scientiﬁc), the bound phages were eluted
with trypsin, which cleaves at a trypsin-site located between the
displayed scFv and protein III. The enzymatic activity was inhibited
by the addition of aprotinin. Eluted phages were propagated by
infection of E. coli XL1-Blue (Stratagene, La Jolla, CA, USA), infected
with M13K07 (New England Biolabs, Beverly, MA, USA) for phage
production and ampliﬁed in solution overnight at 30 C. Harvested
phage stocks were precipitated with polyethylene glycol (PEG),resuspended in PBS containing 0.1% BSA and used for subsequent
rounds of selection. In total, three rounds of selections were carried
out on gradually decreasing amounts of antigen and increasing
number of washes.
Phagemid DNA from the third round of selection was isolated
and recloned to allow production and analysis of soluble scFv. The
DNA was digested with the restriction enzymes SﬁI and AvrII (New
England Biolabs, Ipswich, MA, USA) and ligated into the pHP2-15
vector [27] that provides the secreted scFv with three FLAG-
epitopes and a hexahistidine tag at their C-termini. The constructs
were transformed into Top10 E. coli (Thermo Fisher Scientiﬁc,
Waltham, MA, USA). Single colonies were picked and soluble scFv
produced in 96-well plates containing media supplemented with
isopropyl thiogalactoside (IPTG) by incubation overnight at 37 C
and vigorous shaking (800 rpm). After sedimentation of the
bacteria, the supernatants containing the scFv were screened by
enzyme linked immunosorbent assay (ELISA) for speciﬁc Her2
binding, using an HRP-labeled (horseradish peroxidase – labeled)
anti-FLAG monoclonal antibody (Sigma Aldrich, St. Louis, MO, USA)
as secondary conjugate. Clones that bound to HER2 but not BSA
were subjected to DNA sequencing.
Cloning of human scFv and library into S. carnosus
All scFv constructs, i.e. individual clones as well as pre-enriched
phage library pools, were sub-cloned into the Staphylococcal
display vector pSCEM2 containing restriction sites NotI and AscI
[26]. The scFv genes were ampliﬁed with PCR using primers
containing NotI and AscI site handles and digested with respective
restriction enzymes according to the manufacturer’s instructions
(Thermo Fisher Scientiﬁc). The genes were ligated into pSCEM2
and transformed into E. coli RR1DM15 cells. The single genes were
prepared with QIAprep kit (Qiagen) and the gene library was
prepared with a JETSTAR kit (Genomed, Bad Oeynhausen,
Germany) according to the manufacturer's recommendations
and transformed into electrocompetent S. carnosus TM300 using
a previously described protocol [19]. The displayed scFv cassette on
S. carnosus consisted of pro-peptide (PP) and signal peptide (S) at
the N-terminal, followed by the scFv with an albumin binding
protein (ABP) and a XM domain for cell wall anchoring at the C-
terminal.
Error prone PCR mutagenesis
Error prone mutagenesis of wild type clone SC1 was performed
using GeneMorph II Random Mutagenesis Kit (Agilent Technolo-
gies, Santa Clara, CA, USA) in accordance with the manufacturer’s
instructions. In short, 1 ng plasmid DNA was used as the template
and subjected to 25 cycles of PCR. The resulting library product was
cloned into the vector pSCEM2 and transformed as described
above.
Flow cytometry sorting of S. carnosus libraries (mock library, phage
pre-enriched scFv library and error prone afﬁnity maturation library)
An aliquot of 10 ml of the library corresponding to a number of
cells ten times the size of the library was inoculated in TSB (tryptic
soy broth) with 10 mg/ml chloramphenicol and cultivated at 37 C
for 16 h at 150 < rpm. 10 ml of the overnight culture was washed
with 500 ml PBS-P (PBS with 0.1% Pluronic acid (BASF)) and
pelleted by microcentrifugation (4000g, 4 C, 7 min) and resus-
pended in 200 ml PBS-P containing biotinylated antigen (200 nM
and 100 nM in ﬁrst and second rounds respectively) and incubated
at room temperature under gentle mixing for 2 h. The cells were
thereafter washed with 500 ml PBS-P and resuspended in 200 ml
PBS-P containing streptavidin – R-phycoerythrin (rPE) (1 ng/ml;
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(40 nM), followed by incubation on ice in the dark for 30 min. The
cells were ﬁnally washed with 500 ml PBS-P and re-suspended in
500 ml PBS-P. The library was sorted using a MoFlo Astrios cell
sorter (Beckman Coulter Inc., Brea, CA, USA). The gated cells were
sorted into 200 ml TSB and incubated at 37 C for 2 h under gentle
shaking and thereafter spread onto agar plates containing 10 mg/
ml chloramphenicol. Colonies were screened using PCR and
sequenced with BigDye thermocycle sequencing reactions and
an ABI Prism 3700 instrument (Applied Biosystems, Foster City, CA,
USA).
Flow cytometric analysis of single S. carnosus clones
S. carnosus cells expressing scFvs were cultivated in TSB
medium with 10 mg/ml chloramphenicol for 16 h at 37 C and
150 rpm. Cells were washed with 200 ml PBS-P (PBS with 0.1%
Pluronic acid (BASF)) and pelleted by microcentrifugation (4000g,
4 C, 7 min) and re-suspended in 100 ml PBS-P containing 90 nM
biotinylated antigen and incubated at RT under gentle mixing for
2 h. After incubation, the cells were washed with 200 ml PBS-P and
re-suspended in 100 ml PBS-P containing streptavidin – R-
phycoerythrin (rPE) (1 ng/ml; Life Technologies, Carlsbad, CA,
USA) and human serum albumin (HSA) – Alexa 647 (40 nM),
followed by incubation on ice in the dark for 30 min. The cells were
then washed with 200 ml PBS-P and re-suspended in 200 ml PBS-P,
and analysed by ﬂow cytometry using a Gallios Flow Cytometer
(Beckman Coulter Inc., Brea, CA, USA).
Production of scFv binders as soluble molecules in E. coli
Chosen clones were ampliﬁed with PCR containing SﬁI and AvrII
restriction sites and digested with the corresponding enzymes,
cloned into the pHP2-15 vector and transformed into TOP10 E. coli
cells for expression of soluble molecules. Colonies were inoculated
in Terriﬁc Broth medium containing isopropyl thiogalactoside
(IPTG) and soluble scFv produced overnight at 30 C. The proteins
were puriﬁed from the periplasmic fraction making use of the
hexahistidine tag and HisPurTM Ni-NTA magnetic beads (Thermo
Fisher) following the manufacturer’s recommendation. Sample
elution was performed in PBS containing 500 mM imidazole at
pH8. The eluted scFvs were desalted using dialysis against PBS.
Analysis of scFv molecules on Octet RED96
To conﬁrm successful selection and afﬁnity maturation, the
afﬁnities of the two matured scFvs towards HER2 extracellular
domain (ECD) in comparison with the non-matured scFvs were
measured by biolayer interferometry (BLI) on an Octet RED96
system. Dip and ReadTM Streptavidin (SA) Biosensors (ForteBio)
were hydrated in assay buffer (0.1 mg/ml BSA, 0.002% Tween-20,
PBS) according to the manufacturer’s recommendations and
conditioned by three alternating dips of 5 s each in regeneration
buffer (10 mM glycine, pH 1) and assay buffer. Biotinylated HER2
ECD was immobilised on the hydrated biosensors at a concentra-
tion of 4 mg/ml. Baseline was established in assay buffer.
Association of the scFvs was measured for 10 min in columns at
ﬁve concentrations, from 400 to 25 nM for SC1 and SC1 error2, and
from 200 to 12.5 nM for SC1 error4. Dissociation in assay buffer of
the different scFvs was recorded for 10 min. An unrelated scFv
binding to CTLA-4 was used as reference sensor. The biosensors
were regenerated between the binding cycles as described above.
KD values were calculated based on both association and
dissociation with a 1:1-binding model.Reformatting scFvs as full length monoclonal antibodies
The VH and VL regions of each scFv and the two plasmids [28]
used for mammalian production were ampliﬁed using 50 biotiny-
lated primers (Integrated DNA Technologies, Coralville, IA, USA)
designed with complementary regions of 30 bases for hybrid-
isation. The PCR reactions for the plasmid and inserts were
immobilised using 20 mg of Dynabeads1M-270 Streptavidin beads
in 50 ml immobilisation buffer (2 M NaCl,10% w/v PEG 6000,10 mM
Tris-HCl, 1 mM EDTA, 0.1% Tween 20, pH 7.6). Plasmid and insert
beads were resuspended in 20 ml 0.15 M NaOH for 10 min to allow
for strand elution. Plasmid beads with ssDNA were captured and
allowed to hybridise with eluted insert ssDNA in a mixture of 20 ml
HCl (0.15 M), 10 ml Tris-HCl (1 M, pH 7.4), 10 ml PEG 6000 (50% w/v)
and 20 ml water, preheated to 77 C. The temperature was
decreased by 1 C every 20 s until it reached 50 C, followed by
bead capture and strand extension. The extended constructs on the
beads were released with FastDigest restriction enzyme and the
plasmid containing solution was ligated using T4 ligase (Thermo-
Fisher Scientiﬁc) according to the manufacturer’s instructions. The
ligation mix was ﬁnally used to transform E. coli for plasmid
preparation.
Production of full length antibodies in HEK293T cells
Approximately 2  105 cells per transfection were seeded the
day before in Dulbecco’s Modiﬁed Eagle’s Medium with 5% FBS
(Sigma Aldrich, St. Louis, MO, USA). For each transfection, 2 mg of
heavy chain plasmid and 1 mg of light chain plasmid were mixed
with 6 mg linear polyethylenimine (MW 25,000; Polysciences, PA,
USA) in 200 ml medium. The mixture was then added to the cells
and the antibody containing supernatants were collected after
2 days.
Live cell binding analysis of reformatted full length antibodies
The relative antibody concentrations of the different sample
supernatants were determined using quantitative ELISA Easy-Titer
Human IgG (H + L) Assay Kit (Thermo Fisher Scientiﬁc) according to
the manufacturer’s instructions. The different supernatants were
then diluted to obtain the same relative antibody concentrations in
all samples.
Human ovary adenocarcinoma (SKOV3) cells (LGC- lab stand-
ards AB, Borås, Sweden) with naturally over-expressed surface
HER2, were cultivated in accordance with the manufacturer’s
recommendations, released from culture dishes with trypsin and
washed once with PBS + 1% BSA (PBS:BSA). Approximately 2  105
cells were incubated with antibody containing supernatants with
the following dilution factors: 1/1, 1/2, 1/4, 1/8, 1/16, 1/80, 1/400
and 1/2000 in 100 ml reaction volumes for 2 h at RT. The cells were
washed with 200 ml PBS:BSA followed by incubation with 1 ng/ml
secondary antibody (goat-anti human H + L antibody – rPe
conjugate; 1 ng/ml; Life Technologies, Carlsbad, CA, USA) in
70 ml reaction volume with PBS:BSA for 30 min on ice. The cells
were washed with 200 ml PBS:BSA and re-suspended in 200 ml in a
sample tube. The binding abilities of the scFvs to SKOV3 cells were
evaluated with ﬂow cytometry, using excitation at 560 nm and
measuring ﬂuorescence at FL2 after gating with respect to FSC and
SSC.
Western blot analysis of reformatted full-length antibodies
For SDS-PAGE 1 mm precast NuPAGE Bis-Tris gels (Novex) were
used in a 1 MES running buffer (50 mM MES, 50 mM Tris base,
3,5 mM SDS, 1 mM EDTA). The gel was loaded with 10 ml sample
and 6 ml of SeeBlue Plus2 Protein Standard (ThermoFisher
F.J. Hu et al. / New Biotechnology 45 (2018) 80–88 83Scientiﬁc). Prior to loading, the protein sample was mixed 1:5 with
5 red loading buffer (5 mM EDTA, 433 mM SDS, 3,5 M ß-mer-
captoethanol, 100 mM Tris-HCl, bromophenol blue) and heated for
ﬁve minutes at 95 C. Electrophoresis was performed using a XCell
SureLock Mini-Cell at a constant voltage of 190 V over 30 min. To
transfer the proteins onto a membrane an XCell IITM blot module
(ThermoFisher Scientiﬁc) was used. The PVDF membrane (Ther-
moFisher Scientiﬁc) was ﬁrst activated in methanol and equili-
brated in transfer buffer (25 mM Bicine, 25 mM BisTris, 0,8 mM
EDTA, pH 7,2, 10% Ethanol). The transfer was performed at a
constant voltage of 30 V for 90 min at 4 C. The membrane was
blocked with milk powder (5% milk powder, 0,5% Tween20 in 1
TBS-T) over night at 4 C. The blot was incubated with goat anti-
human horseradish peroxidase (HRP) conjugated antibody (Ther-
moFisher Scientiﬁc) diluted 1:5000 in blocking buffer for 1 h at RT
on a rotation mixer. After the ﬁrst incubation step the blot was
washed three times with TBS-T. To develop the blot the Immobilon
Western Chemiluminescent horseradish peroxidase (HRP) Sub-
strate (Merck Millipore, Billerica, MA, USA) was used according to
the manufacturer's instructions. An image of the developed blot
was captured using a BioRad CCD camera and software.Fig. 1. A) Schematic representation of the staphylococcal cell surface. The fusion protein
antibody fused to an albumin binding protein (ABP) is anchored to the cell wall by the pro
study. C) Selection procedure for ﬂuorescent ﬂow cytometric sorting of bacterial scFv li
cloned into S. carnosus cells. (2) Cells are incubated with labeled target and human serum a
right corner, circled) are collected (4) for subsequent rounds (5) or characterisation.Results
As illustrated in Fig. 1, we present a work scheme for display,
selection and screening of human scFv libraries using S. carnosus
display coupled to ﬂow cytometric sorting, after initial enrichment
by phage display. The scFv displayed on S. carnosus is preceded by a
pro-peptide (PP) and signal peptide (S) at the N-terminal and has
an albumin binding protein (ABP) and a XM domain for cell wall
anchoring at the C-terminal (Fig. 1A–B). During the selection
process (Fig. 1C), target-enriched phage-clones are transferred to S.
carnosus and incubated with a biotinylated antigen. A second
incubation with streptavidin-r-PE and labeled normalisation
protein (HSA – 647) allows for two-colour ﬂuorescent sorting
with ﬂow cytometry. The degree of binding strength to the antigen
is determined by the magnitude of the signal from r-PE (Y-axis,
signal FL2). The labeled normalisation protein binds to the ABP
domain of the expression cassette and is used for normalisation
and assessment of the expression level (X-axis, signal FL6).
According to previous studies, the average expression level has
been estimated to be about 104–105 recombinant proteins per cell
[29]. Cells of interest, exhibiting high binding and surface containing the pro-peptide (PP), the heavy (VH) and light chain domains (VL) of the
cessed XM’ domain. B) The pSCEM2 vector with the expression cassette used in this
braries. (1) A human synthetic scFv library is pre-selected using phage display and
lbumin. (3) Clones are sorted using ﬂow cytometry and the strongest binders (upper
84 F.J. Hu et al. / New Biotechnology 45 (2018) 80–88expression (upper right corner) may be sorted by selecting a
desired gate, ampliﬁed by overnight cultivation and either
subjected to following rounds of sorting or isolation for
characterisation as single clones.
Fluorescence detection and enrichment of cells expressing scFv on the
surface of S. carnosus from a mock library
Herceptin (Trastuzumab) in its full-length antibody form binds
with high afﬁnity to HER2. We cloned Herceptin as an scFv with a
translocation signal for expression and anchoring to the surface of
S. carnosus [30] under the control of a constitutive promoter
(Fig. 1). Transformed cells were detected in the ﬂow cytometer by
the size and granularity parameters, forward (FS) and side scatter
(SS) (Fig. 2A). HER2 binding was detected with biotinylated HER2
and streptavidin-rPE (FL2) whereas surface expression was
detected with HSA – 647 (FL6). We observed a clear surface
expression signal at 40 nM HSA – Alexa 647 for both Herceptin scFv
(73% of cells within FL6 gate) and an anti-CTLA4 scFv (63% of cells
within FL6 gate) (Fig. 2B–C).
In the next step, we generated a mock library with Herceptin
scFv clones spiked into a background of anti-CTLA4 scFv clones at a
ratio of 1:10,000. The purpose of this experiment was to verify thatFig. 2. FACS-based Enrichment of Herceptin scFv in a mock library of CTLA4 scFv clon
A) Forward (FS) and side (SS) scatter dot plot showing detectability of S. carnosus display
construct was performed using HSA-Alexa 647 binding the ABP domain downstream of t
the surface of S. carnosus as evidenced by FL6 signal. Detection of antigen binding (FL2) w
Herceptin scFv diluted in excess of an anti-CTLA4 scFv at 1:10,000 ratio was subjected to t
Herceptin scFv from the mock library can be clearly seen following two rounds of sortthe platform could be used to enrich positive binders against a
target protein from negative binders in a library size similar to that
typically obtained after initial pre-enrichment of a naïve library by
phage. Flow cytometric cell sortings yielded enrichment after each
round, and after two rounds of selection the ratio of Herceptin scFv
to CTLA-4 scFv was 1:15 clones (Fig. 2D–F). This shows the
possibility of using FACS to enrich human scFv in Gram-positive
display libraries.
Isolation of binders from pre-enriched antibody libraries using Gram-
positive display
To further challenge the system, we used S. carnosus as a
platform for library selection of novel antibody fragments speciﬁc
for HER2. Prior to bacterial surface display, three rounds of phage
selections on HER2 were performed using a human synthetic scFv
library (Hell-11) of >1010 members complexity [27]. The resulting
library containing the scFvs from the third round of phage panning
was cloned into the pSCEM2 vector and transformed into S.
carnosus cells yielding a library of 104 transformants [23].
Screening and cytometric sorting of this library was ﬁrst
performed using 200 nM labeled HER2 and 40 nM HSA – 647
(Fig. 3A). 3.8% of the population was gated and sorted as potentiales.
ing Herceptin scFv in a ﬂow cytometer. Surface expression (FL6) monitoring of scFv
he scFv. Graphic proﬁle of anti-CTLA4 B) and Herceptin C) scFv expression signal on
as performed using biotin labeled HER2 and streptavidin-rPE. A mock library with
wo rounds of sorting by gating for enhanced binding in dot plots D–F). Enrichment of
ing (F) as evidenced by an increased population in the selected gate.
Fig. 3. FACS sorting of anti-HER2 scFvs from pre-enriched library and characterisation of selected binders.
(A) Selection of scFv binders from a pre-enriched library against HER2 using FACS. A total of two rounds of sorting were performed whereby cells were sorted into the
designated gate and subjected to another round of sorting (A). A clear enrichment was seen after two rounds of sorting (A, rightmost panel).
(B) Individual ﬂow cytometry analysis of a selected scFv clone (SC1) displayed on S. carnosus (left panel). Flow cytometry overlay of scFv clones labeled with HER2 (right
panel). An anti-CTLA4 and Herceptin in displayed form on S. carnosus were used as a negative and positive control respectively. ScFv clones selected by FACS sorting SC1, SC39
and SC66, exhibited different degrees of binding, as evidenced by the different MFI values.
(C) Analysis of scFvs reformatted to full-length antibodies was performed with Western blot (left) and ﬂow cytometry binding assay to SKOV3 cells (right). Western blot
analysis was performed on medium supernatants collected from transfected HEK293T cells (lanes 1–6: un-transfected cells; Herceptin; anti-CTLA4; SC1; SC39; SC66) to
conﬁrm the presence of the heavy and light chains of each antibody (C, left panel). HER2 expressing SKOV3 cells were incubated with antibodies listed. Anti-CTLA4 antibody
(black) and Herceptin (red) were used as negative and positive controls respectively and all reformatted HER2-binders selected were able to bind SKOV3 to slightly varying
degrees.
F.J. Hu et al. / New Biotechnology 45 (2018) 80–88 85HER2-binding clones (Fig. 3A, left). These sorted cells were
expanded and subjected to an additional round of sorting under
similar conditions (100 nM labeled HER2 and 40 nM HSA – 647)
where 3.2% of the population was sorted (Fig. 3A, middle). A clear
enrichment could be seen following these two rounds of
cytometric sorting (Fig. 3A, right).
Characterisation of individual selected clones
We picked 96 positive single clones after two rounds of library
sorting for on-cell ﬂow cytometry analysis. The clones were ranked
based on mean ﬂuorescence intensity of antigen binding (FL2)
while also taking surface expression (FL6) into consideration and
96 clones were sequenced of which 18 sequences were unique. The
three best clones (SC1, SC39 and SC66) were chosen for a more
detailed analysis. This involved ﬂow cytometry analysis using scFv
in surface displayed form (Fig. 3B), as well as afﬁnity determina-
tion by BLI using puriﬁed soluble scFv molecules (Table 1) and live
cell HER2 binding using scFv reformatted as full length monoclonal
antibodies (Fig. 3C).Clonal on-cell ﬂow cytometry analysis of the binders conﬁrmed
binding to native HER2 for all binders, with a slightly varying
binding characteristics for each clone (Fig. 3B). Cells were
incubated with the same concentration of labeled HER2, followed
by measurement of FL2 median antigen binding signal (Fig. 3B
right) in the gate containing surface expressed clones (Fig. 3B left).
The data shows that Herceptin in scFv-displayed form had the
highest amount of bound HER2, as evidenced by the highest
ﬂuorescence signals. Taking only the antigen binding signal (FL2)
into account, SC1 had the highest antigen binding of the three
isolated clones followed by SC66 and SC39. This ranking remains
when normalizing the antigen binding signal (FL2) to the surface
expression signal (FL6) (Table 1, Supplementary Fig. S1), but the
stronger binding of SC66 compared to SC39 becomes more
pronounced. As expected, the negative control CTLA-4 showed
no binding.
Afﬁnity measurements with scFvs produced as soluble proteins
were performed using BLI (Table 1, Supplementary Fig. S2). As a
validation control, the afﬁnity parameters of Herceptin scFv were
determined (KD= 0.4 nM; kon = 2.3E5 M1 s1; kdis= 9.8E–5 s1),
Table 1
Afﬁnity Parameters.
Name KD (M) kon (1/Ms) kdis (1/s) Surface expression normalised antigen binding (FL2/FL6)
SC1 11.9 E-9  4.9 E-9 1.4E + 05  5.6E + 04 1.5E-03  7.1E-06 0.1
SC39 3.2 E-7  2.1 E-7 2.4E + 04  2.4E + 04 1.0E-02  1.0E-02 0.03
SC66 13.9 E-9  6.0 E-9 2.3E + 05  1.1E + 05 2.8E-03  1.4E-04 0.06
SC1M2 2.8 E-09  3.5 E-10 1.5E + 05  7.8E + 04 3.9E-04  1.7E-04 0.12
SC1M4 2.2 E-09  7.1 E-11 3.6E + 05  1.3E + 05 7.5E-04  2.5E-04 0.22
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binder with the strongest relative target afﬁnity when displayed on
S. carnosus (SC1) also had the strongest afﬁnity, with a KD value of
12 nM. The measured KD values of SC66 and SC39 were 14 nM and
300 nM respectively. The KD values determined by BLI were
consistent with the clonal ranking on staphylococcal cells (Fig. 3B)
and surface expression normalised antigen binding (Table 1,
Supplementary Fig. S1). Taken together these experiments suggest
that Gram-positive display enables the isolation of high-afﬁnity
binders from a human antibody library.
Characterisation of selected clones reformatted as full length human
monoclonal antibodies
Since functional full-length monoclonal antibodies are often
desired for therapeutic purposes, the selected binders (SC1, SC39,
SC66) were cloned as full length antibodies. Cloning of the scFvs
into human constant region frameworks for both heavy and light
chains was performed using automated robot cloning [28]. The
constructs were used to transfect HEK293T cells and a Western blot
analysis was conducted to conﬁrm that the monoclonal antibodies
were produced in comparable amounts (Fig. 3C, left). The
antibody-containing medium supernatants were then used to
assess binding on live SKOV3 cells using ﬂow cytometry (Fig. 3C,
right). The antibody levels in each sample supernatant was ﬁrstFig. 4. FACS sorting of error prone-PCR library allows isolation of afﬁnity matured scF
FACS sorting of afﬁnity matured scFv binder after error prone PCR. The wild type SC1 w
enhanced afﬁnity (A). The two unique binders that were selected (SC1 M2 and SC1 M4) w
HER2, with the signal from HER2 binding shown on the X-axis (FL2) and frequency ondetermined using ELISA and the different sample supernatants
then adjusted for slight variations in antibody concentrations
before incubation with SKOV3 cells and measurement of median
ﬂuorescence by ﬂow cytometry. As expected, the full-length forms
of Herceptin, SC1, SC66 and SC39 were all positive in SKOV3
binding with Herceptin having the highest signals. Furthermore,
we observed the same relative ranking of binding strength
between the samples when compared to the two previous assays
(ranking on S. carnosus and using BLI). We could therefore conclude
that the binding characteristics obtained from the clones in scFv
format on S. carnosus are retained when reformatted into full-
length antibodies.
Afﬁnity maturation of wild type SC1 and isolation of mutants with
enhanced afﬁnities
One of the selected binders (SC1) was subjected to afﬁnity
maturation using error prone PCR. The resulting 104 library with an
average of two mutated amino acids per gene, was sorted by ﬂow-
cytometry in a similar manner as the phage pre-enriched library
(Fig. 4A). Two isolated binders from the afﬁnity maturation library
(SC1M2, SC1M4) were again selected for detailed analysis. Clonal
characterisation using both on cell ﬂow cytometry analysis using
scFv in surface anchored form (Fig. 4B) as well as afﬁnity
characterisation using BLI of soluble scFv molecules (Table 1,v.
as subjected to error prone PCR and ﬂow cytometric sorting to ﬁnd binders with
ere analysed using on-cell ﬂow cytometry (B). The cells were incubated with labeled
 the Y-axis. Both SC1 M2 and SC1 M4 have improved afﬁnities against HER2.
F.J. Hu et al. / New Biotechnology 45 (2018) 80–88 87Supplementary Fig. S2) showed improved binding for both afﬁnity
maturated mutants, of which SC1M4 showed the largest improve-
ment of afﬁnity. The association and dissociation constants
(Table 1) and the sensorgrams (Supplementary Fig. S2) illustrate
that this improvement was due to both a higher on- and a slower
off-rate. Although SC1M2 appears very close to SC1 in the ﬂow
cytometry analysis (Fig. 4B), when looking at the antigen binding
signal (FL2) only, the improvement in afﬁnity is clearer visualised
when accounting for SC1M2’s surface expression (Table 1,
Supplementary Fig. S3). This highlights the utility of the
simultaneous monitoring of binding and surface expression for
the ranking of clones. Both the stronger binder SC1M4, with
mutations in three positions, as well as SC1M2, with one mutation,
had mutations located outside the CDRs (Supplementary Fig. S4).
Despite the modest improvement in afﬁnity, we are able to
demonstrate the possibility of using S. carnosus for afﬁnity
maturation of human scFv without the need for phage display.
Discussion
In this paper we present the ﬁrst use of Gram-positive bacteria
for display of human antibody libraries. We have shown that Gram-
positive bacterial display can be used to isolate human scFvs with
low nanomolar dissociation constants from a human antibody
library pre-enriched by phage display. By combining bacterial
display with phage display, we were able to use the advantages of
both platforms. While phage display enables generation of larger
libraries than bacterial display, the latter allows for thorough and
fast screening and enrichment of binders using ﬂow cytometry
sorting, the equivalent of thousands of individual ELISA screening
assays of E. coli expressed scFv proteins [34]. Furthermore, ﬂow
cytometric sorting enables the possibility of monitoring the
binding process in real-time and gating a binding population for
sorting of clones for subsequent rounds of selection and or
downstream characterisation. A more stringent deﬁnition of the
desired gate can be used to further minimise the sorting of non-
binding clones. We have chosen to monitor ﬂuorescent signal for
both binding and surface display to allow sorting of clones based
on their apparent afﬁnity rather than their abundance on the cell
surface. In the case of the three top binders identiﬁed by FACS here,
none was present in an initial ELISA screening (47 clones) of the
phage pre-selected library and only two (SC1 and SC66) were
found after a more thorough ELISA screening (approx. 300 clones),
whereas the third (SC39) could not be found. This was likely due to
it being present in a much lower abundance and therefore
requiring more time and effort to be successfully found by
microtiter plate ELISA. Since the combination of phage display and
deep sequencing allows for the time- and labour-efﬁcient
identiﬁcation of rare binders [35,36], we believe it would also
be interesting to combine phage display and deep sequencing with
this screening platform to validate the functional binding of such a
variety of clones.
By characterising the selected binders, we have also found that
the relative binding ranking of the scFv displayed on S. carnosus is
in line with the ranking of KD values determined by BLI as well as
ranking of binding to native HER2 present on SKOV3 cells using
scFv reformatted as full length antibodies. Another potential
beneﬁt of selecting binders through a series of orthogonal selection
systems could be the isolation of robust proteins with better
general folding behaviour. This would be a desirable trait both as
scFv or expressed as full-length proteins in a mammalian
production host, as conversion of a phage display selected scFv
into full length IgG may lead to a decrease in afﬁnity [37]. In
addition, switching expression system and afﬁnity gating normal-
ised on expression level could circumvent potential ampliﬁcationor toxic biases that are sometimes observed in phage display
systems [38].
As a ﬁnal step, the staphylococcal display system was used
successfully to afﬁnity mature one of the earlier selected binders to
show that this platform provides an efﬁcient and streamlined
approach to yield high-afﬁnity binders. Although the mutations of
both afﬁnity matured clones were located outside the CDR-regions,
we speculate that future usage of S. carnosus scFv libraries with
diversity introduced in the CDRs using synthetic oligonucleotides
is a viable alternative to error-prone PCR based libraries, with the
potential to give an even better improvement in afﬁnity.
In summary, we believe the technology we have developed here
by combining phage display with staphylococcal display allows for
a rapid and efﬁcient generation of robust, high-afﬁnity binders and
aids the identiﬁcation of low abundance library variants. Previous
applications of this display platform together with observations
noted in this study indicate that S. carnosus display can be utilised
to complement existing technologies, particularly in combination
with phage display. This is also the ﬁrst time that human antibody
fragments (scFv) have been subjected to library selection on Gram-
positive bacteria. It would thus be interesting to perform selections
against several other targets and compare the results with other
platforms on a larger scale by utilising massively parallel
sequencing methods [39–41].
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